D-0703-2021 Class II Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0703-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jul 29, 2021 and is designated Class II. Reason for recall: Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg The recall status is terminated (terminated Jun 8, 2023). Affected quantity: 2856 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 18, 2021
Initiation Date
Jul 29, 2021
Termination Date
Jun 8, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2856 bottles

Product description

Venlafaxine Tablets, USP 50 mg*, 100 Tablets Manufactured for Northstar Rx LLC Memphis, TN 38141 Manufactured by: ALKALOIDA Chemical Company Zrt. 4440 Tiszavasvari, Kabay Janos u.29.Hungary. Product of India NDC 16714-657-01

Reason for recall

Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg

Distribution pattern

Northstar Distribution Center 4853 Crumpler Rd. Memphis, TN 38141

Code information

AVK1175A, exp 9/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0703-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0703-2021. Report a data issue: hello@regdatalab.com.